Guggenheim Capital LLC Danaher Corp Transaction History

Guggenheim Capital LLC

  • $13.9 Billion
  • Q2 2024

A detailed history of Guggenheim Capital LLC transactions in Danaher Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 27,625 shares of DHR stock, worth $6.71 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
27,625
Previous 29,452 6.2%
Holding current value
$6.71 Million
Previous $7.35 Million 6.15%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$235.51 - $267.98 $430,276 - $489,599
-1,827 Reduced 6.2%
27,625 $6.9 Million
Q1 2024

May 14, 2024
SELL
$224.58 - $256.19 $509,572 - $581,295
-2,269 Reduced 7.15%
29,452 $7.35 Million
Q4 2023

Feb 14, 2024
SELL
$185.1 - $233.13 $4,072 - $5,128
-22 Reduced 0.07%
31,721 $7.34 Million
Q3 2023

Nov 14, 2023
SELL
$233.08 - $265.59 $158,261 - $180,335
-679 Reduced 2.09%
31,743 $7.88 Million
Q2 2023

Aug 11, 2023
SELL
$224.99 - $256.14 $136,118 - $154,964
-605 Reduced 1.83%
32,422 $7.78 Million
Q1 2023

May 10, 2023
BUY
$239.75 - $277.0 $230,399 - $266,197
961 Added 3.0%
33,027 $8.32 Million
Q4 2022

Feb 14, 2023
BUY
$241.42 - $282.29 $2.62 Million - $3.06 Million
10,836 Added 51.04%
32,066 $8.51 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $13,341 - $81,399
-54 Reduced 0.25%
21,230 $5.48 Million
Q2 2022

Aug 15, 2022
SELL
$237.11 - $299.66 $1.69 Million - $2.14 Million
-7,131 Reduced 25.1%
21,284 $5.4 Million
Q1 2022

May 16, 2022
SELL
$257.27 - $315.76 $393,365 - $482,797
-1,529 Reduced 5.11%
28,415 $8.34 Million
Q4 2021

Feb 14, 2022
BUY
$292.08 - $329.01 $1.4 Million - $1.57 Million
4,782 Added 19.0%
29,944 $9.85 Million
Q3 2021

Nov 15, 2021
BUY
$272.21 - $332.43 $173,669 - $212,090
638 Added 2.6%
25,162 $7.66 Million
Q2 2021

Aug 13, 2021
BUY
$225.08 - $271.69 $437,105 - $527,621
1,942 Added 8.6%
24,524 $6.58 Million
Q1 2021

May 13, 2021
SELL
$212.38 - $245.9 $565,992 - $655,323
-2,665 Reduced 10.56%
22,582 $5.08 Million
Q4 2020

Feb 16, 2021
BUY
$212.5 - $245.46 $527,850 - $609,722
2,484 Added 10.91%
25,247 $5.61 Million
Q3 2020

Nov 13, 2020
SELL
$177.16 - $215.33 $3.27 Million - $3.98 Million
-18,479 Reduced 44.81%
22,763 $4.9 Million
Q2 2020

Aug 14, 2020
BUY
$128.7 - $176.83 $3.06 Million - $4.21 Million
23,783 Added 136.22%
41,242 $7.29 Million
Q1 2020

Jun 02, 2020
SELL
$121.39 - $169.05 $3.77 Million - $5.25 Million
-31,031 Reduced 63.99%
17,459 $2.42 Million
Q4 2019

Feb 14, 2020
BUY
$133.47 - $153.48 $2.45 Million - $2.82 Million
18,350 Added 60.88%
48,490 $7.44 Million
Q3 2019

Nov 14, 2019
SELL
$135.4 - $146.47 $1.15 Million - $1.25 Million
-8,515 Reduced 22.03%
30,140 $4.35 Million
Q2 2019

Aug 14, 2019
SELL
$124.88 - $143.73 $1.18 Million - $1.36 Million
-9,439 Reduced 19.63%
38,655 $5.52 Million
Q1 2019

May 15, 2019
SELL
$97.62 - $132.29 $1.85 Million - $2.51 Million
-18,997 Reduced 28.32%
48,094 $6.35 Million
Q4 2018

Feb 14, 2019
SELL
$94.85 - $109.54 $5.11 Million - $5.9 Million
-53,866 Reduced 44.53%
67,091 $6.92 Million
Q3 2018

Nov 14, 2018
BUY
$98.13 - $108.9 $2.23 Million - $2.48 Million
22,759 Added 23.18%
120,957 $13.1 Million
Q2 2018

Aug 14, 2018
SELL
$96.1 - $103.24 $72.6 Million - $77.9 Million
-754,981 Reduced 88.49%
98,198 $9.69 Million
Q1 2018

May 15, 2018
SELL
$92.16 - $103.8 $2.48 Million - $2.79 Million
-26,890 Reduced 3.06%
853,179 $83.5 Million
Q4 2017

Feb 14, 2018
BUY
$85.26 - $94.62 $651,471 - $722,991
7,641 Added 0.88%
880,069 $81.7 Million
Q3 2017

Nov 14, 2017
BUY
$79.29 - $88.45 $69.2 Million - $77.2 Million
872,428
872,428 $74.8 Million

Others Institutions Holding DHR

# of Institutions
2,432
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.11M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email